MINSTER MEDICAL PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: C83072 | LINCOLN, LN2 2JP
Showing results 451-500 of 606
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 23 | 16.2K | £1.1K | -39.7% ▼ | |
| 23 | 760 | £1.8K | +144.8% ▲ | |
| Sennosides | 22 | 11.2K | £217 | -28.8% ▼ |
| Hydralazine hydrochloride | 22 | 980 | £51 | -47.9% ▼ |
| Moxonidine | 22 | 868 | £144 | -60.5% ▼ |
| Ipratropium bromide | 22 | 1,760 | £486 | -23.5% ▼ |
| Hyoscine hydrobromide | 22 | 1,644 | £262 | -35.6% ▼ |
| Empagliflozin/metformin | 22 | 1,624 | £1.0K | -57.7% ▼ |
| Ciclosporin | 22 | 1,320 | £1.1K | +31.8% ▲ |
| Brinzolamide and timolol | 22 | 195 | £328 | -41.8% ▼ |
| Ketorolac trometamol | 22 | 115 | £101 | +137.1% ▲ |
| Chlorhexidine gluconate | 22 | 7,150 | £490 | -25.5% ▼ |
| 22 | 105 | £670 | +72.9% ▲ | |
| Hydroxyzine hydrochloride | 21 | 868 | £28 | -60.6% ▼ |
| Nefopam hydrochloride | 21 | 2,310 | £101 | -81.4% ▼ |
| Valproic acid | 21 | 630 | £131 | +43.6% ▲ |
| Triptorelin acetate | 21 | 21 | £1.4K | +46.5% ▲ |
| Pyridostigmine bromide | 21 | 4,200 | £328 | +22.7% ▲ |
| Other individually formulated bought in preparations | 21 | 344 | £626 | -35.7% ▼ |
| 21 | 550 | £2.7K | +66.0% ▲ | |
| Linaclotide | 20 | 560 | £714 | +9.5% ▲ |
| Aspirin | 20 | 618 | £150 | +103.5% ▲ |
| Oxcarbazepine | 20 | 1,120 | £617 | -28.5% ▼ |
| Galantamine | 20 | 560 | £1.1K | -47.1% ▼ |
| 20 | 1,350 | £69 | -63.2% ▼ | |
| Labetalol hydrochloride | 19 | 1,064 | £107 | -16.3% ▼ |
| Alimemazine tartrate | 19 | 532 | £1.3K | +47.0% ▲ |
| Almotriptan | 19 | 198 | £427 | +53.3% ▲ |
| Rotigotine | 19 | 588 | £2.5K | -29.6% ▼ |
| Acamprosate calcium | 19 | 2,058 | £226 | -45.4% ▼ |
| Glucose | 19 | 2,245 | £197 | -63.5% ▼ |
| Dexamethasone | 19 | 789 | £72 | -39.0% ▼ |
| Powder amino acid formula (0913107) | 19 | 80.4K | £5.1K | -42.5% ▼ |
| Leflunomide | 19 | 570 | £33 | -49.8% ▼ |
| Erythromycin | 19 | 1,320 | £567 | +39.9% ▲ |
| Permethrin | 19 | 930 | £277 | -49.6% ▼ |
| 19 | 825 | £123 | -29.3% ▼ | |
| 19 | 220 | £606 | -60.3% ▼ | |
| 19 | 310 | £187 | -75.4% ▼ | |
| Fenofibrate | 18 | 672 | £71 | -81.4% ▼ |
| Erythromycin ethylsuccinate | 18 | 2,900 | £214 | -22.9% ▼ |
| Biphasic insulin lispro | 18 | 300 | £1.9K | -58.1% ▼ |
| Glucagon | 18 | 18 | £208 | +18.3% ▲ |
| Testosterone esters | 18 | 23 | £54 | +22.1% ▲ |
| Betamethasone sodium phosphate | 18 | 185 | £47 | -30.5% ▼ |
| Sodium chloride | 18 | 282 | £586 | +172.0% ▲ |
| Betamethasone esters | 18 | 1,080 | £91 | -70.2% ▼ |
| 18 | 310 | £230 | -54.3% ▼ | |
| 18 | 780 | £1.5K | +40.7% ▲ | |
| 18 | 180 | £546 | -11.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.